Loreto Carmona to Aged
This is a "connection" page, showing publications Loreto Carmona has written about Aged.
Connection Strength
0.095
-
Launch and preliminary analysis of Hospital de La Princesa's inter-specialists biological therapies unit. Reumatol Clin (Engl Ed). 2019 Mar - Apr; 15(2):63-68.
Score: 0.014
-
Second Hip Fracture: Incidence, Trends, and Predictors. Calcif Tissue Int. 2018 06; 102(6):619-626.
Score: 0.013
-
Trends in osteoporotic hip fracture epidemiology over a 17-year period in a Spanish population: Alcorcón 1999-2015. Arch Osteoporos. 2017 Sep 27; 12(1):84.
Score: 0.013
-
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Ann Rheum Dis. 2021 09; 80(9):1137-1146.
Score: 0.004
-
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2021 07; 80(7):930-942.
Score: 0.004
-
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Ann Rheum Dis. 2020 12; 79(12):1544-1549.
Score: 0.004
-
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020 07; 79(7):859-866.
Score: 0.004
-
Satisfaction, fulfillment of expectations and adherence to subcutaneous biological drugs in patients with rheumatoid arthritis: ARCO study. Reumatol Clin (Engl Ed). 2020 Mar - Apr; 16(2 Pt 1):116-119.
Score: 0.003
-
Weather conditions and their effect on seasonality of incident osteoporotic hip fracture. Arch Osteoporos. 2018 Mar 15; 13(1):28.
Score: 0.003
-
The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches. Rheumatol Int. 2018 May; 38(5):905-915.
Score: 0.003
-
Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study. Clin Exp Rheumatol. 2018 May-Jun; 36(3):382-388.
Score: 0.003
-
2013 ACR/EULAR systemic sclerosis classification criteria in patients with associated pulmonary arterial hypertension. Semin Arthritis Rheum. 2018 06; 47(6):870-876.
Score: 0.003
-
Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis. Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 106(4):114-121.
Score: 0.003
-
Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study. Rheumatol Int. 2017 Jul; 37(7):1195-1202.
Score: 0.003
-
Early Mortality in a Multinational Systemic Sclerosis Inception Cohort. Arthritis Rheumatol. 2017 05; 69(5):1067-1077.
Score: 0.003
-
Cardiovascular risk of patients with gout seen at rheumatology clinics following a structured assessment. Ann Rheum Dis. 2017 Jul; 76(7):1263-1268.
Score: 0.003
-
Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study. Clin Exp Rheumatol. 2017 May-Jun; 35(3):423-430.
Score: 0.003
-
Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis. PLoS One. 2016; 11(12):e0166691.
Score: 0.003
-
Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis. Arthritis Rheumatol. 2015 Jan; 67(1):117-27.
Score: 0.003